The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease
Abstract
Celiac disease is a T cell-driven intolerance to wheat gluten. The gluten-derived T cell epitopes are proline-rich and thereby highly resistant to proteolytic degradation within the gastrointestinal tract. Oral supplementation with prolyl oligopeptidases has therefore been proposed as a potential therapeutic approach. The enzymes studied, however, have limitations as they are irreversibly inactivated by pepsin and acidic pH, both present in the stomach. As a consequence, these enzymes will fail to degrade gluten before it reaches the small intestine, the site where gluten induces inflammatory T cell responses that lead to celiac disease. We have now determined the usefulness of a newly identified prolyl endoprotease from Aspergillus niger for this purpose. Gluten and its peptic/tryptic digest were treated with prolyl endoprotease, and the destruction of the T cell epitopes was tested using mass spectrometry, T cell proliferation assays, ELISA, reverse-phase HPLC, SDS-PAGE, and Western blotting. We observed that the A. niger prolyl endoprotease works optimally at 4–5 pH, remains stable at 2 pH, and is completely resistant to digestion with pepsin. Moreover, the A. niger-derived enzyme efficiently degraded all tested T cell stimulatory peptides as well as intact gluten molecules. On average, the endoprotease from A. niger degraded gluten peptides 60 times faster than a prolyl oligopeptidase. Together these results indicate that the enzyme from A. niger efficiently degrades gluten proteins. Future studies are required to determine if the prolyl endoprotease can be used as an oral supplement to reduce gluten intake in patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structural Basis for Gluten Intolerance in Celiac Sprue
Shan, L., Molberg, Ø., Parrot, I., Hausch, F., Filiz, F., Gray, G. M., Sollid, L. M., & Khosla, C. (2002) · Science · doi:10.1126/science.1074129 · Cited by 1,576
Molberg, Ø., Mcadam, S. N., Körner, R., Quarsten, H., Kristiansen, C., Madsen, L., Fugger, L., Scott, H., Norén, O., Roepstorff, P., et al. (1998) · Nature Medicine · doi:10.1038/nm0698-713 · Cited by 1,168
Arentz-Hansen, H., Körner, R., Molberg, Ø., Quarsten, H., Vader, W., Kooy, Y. M. C., Lundin, K. E. A., Koning, F., Roepstorff, P., Sollid, L. M., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.4.603 · Cited by 654
Self-citationvan de Wal, Y., Kooy, Y. M. C., van Veelen, P. A., Peña, S., Mearin, L., Papadopoulos, G. K., & Koning, F. (1998) · PubMed · Cited by 490
Self-citationvan de Wal, Y., Kooy, Y., van Veelen, P., Peña, S., Mearin, L., Papadopoulos, G., & Koning, F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1585 · Cited by 432
Self-citationSpecificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease
Vader, L. W., de Ru, A., van der Wal, Y., Kooy, Y. M. C., Benckhuijsen, W., Mearin, M. L., Drijfhout, J. W., van Veelen, P., & Koning, F. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012028 · Cited by 357
Self-citationSpaenij–Dekking, L., Kooy–Winkelaar, Y., van Veelen, P., Wouter Drijfhout, J., Jonker, H., van Soest, L., Smulders, M. J. M., Bosch, D., Gilissen, L. J. W. J., & Koning, F. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.017 · Cited by 251
Self-citationSHAN, L., MARTI, T., SOLLID, L. M., GRAY, G. M., & KHOSLA, C. (2004) · Biochemical Journal · doi:10.1042/bj20040907 · Cited by 241
Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin
van de Wal, Y., Kooy, Y. M. C., van Veelen, P. A., Peña, S. A., Mearin, L. M., Molberg, Ø., Lundin, K. E. A., Sollid, L. M., Mutis, T., Benckhuijsen, W. E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10050 · Cited by 236
Self-citationMarti, T., Molberg, Ø., Li, Q., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.073312 · Cited by 132
Catassi, C., Rossini, M., Rätsch, I. M., Bearzi, I., Santinelli, A., Castagnani, R., Pisani, E., Coppa, G. V., & Giorgi, P. L. (1993) · Gut · doi:10.1136/gut.34.11.1515 · Cited by 124
Edens, L., Dekker, P., van der Hoeven, R., Deen, F., de Roos, A., & Floris, R. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf050652c · Cited by 120
Self-citationMatysiak‐Budnik, T., Candalh, C., Cellier, C., Dugave, C., Namane, A., Vidal–Martinez, T., Cerf–Bensussan, N., & Heyman, M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.016 · Cited by 98
Cited by
Green, P. H. R., & Cellier, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071600 · Cited by 1,625
Celiac Disease: From Pathogenesis to Novel Therapies
Schuppan, D., Junker, Y., & Barisani, D. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.008 · Cited by 606
Celiac disease: pathogenesis of a model immunogenetic disease
Kagnoff, M. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30253 · Cited by 386
Biotechnological Applications of Proteases in Food Technology
Tavano, O. L., Berenguer‐Murcia, A., Secundo, F., & Fernandez‐Lafuente, R. (2018) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12326 · Cited by 294
Advances in Celiac Disease and Gluten-Free Diet
Niewinski, M. M. (2008) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2008.01.011 · Cited by 280
Metadata
- Authors
- Stepniak, D., Spaenij-Dekking, L., Mitea, C., Moester, M., de Ru, A., Baak-Pablo, R., van Veelen, P., Edens, L., & Koning, F.
- Venue
- American Journal of Physiology-Gastrointestinal and Liver Physiology
- Publisher
- American Physiological Society
- Published
- 2006-10
- Volume
- 291
- Issue
- 4
- Pages
- G621-G629
- ISSN
- 0193-1857 (ISSN-L)
- 1522-1547
- OpenAlex
- W2107555364
- Cited by
- 297
- References
- 13
- FWCI
- 12.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.